Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

OTC ANTIHISTAMINE META-ANALYSIS SHOWS 10%-15% MORE PATIENTS OBTAINED RELIEF

This article was originally published in The Tan Sheet

Executive Summary

OTC ANTIHISTAMINE META-ANALYSIS SHOWS 10%-15% MORE PATIENTS OBTAINED RELIEF from cold symptoms in the drug groups than from placebo, FDA consultant Ralph D'Agostino, PhD, Boston University, reported in a Nov. 15 presentation to FDA's Nonprescription Drugs and Pulmonary-Allergy Drugs Advisory Committees. Reporting on the results of a meta-analysis of antihistamine studies in the common cold, D'Agostino said the data "indicate superiority of the antihistamine over the placebo" with a "10%-15% improvement in the drug group versus the placebo group."
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS083454

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel